Welcome to our dedicated page for MEDLINE news (Ticker: MDLN), a resource for investors and traders seeking the latest updates and insights on MEDLINE stock.
Medline Inc. (Nasdaq: MDLN) is a healthcare company focused on medical-surgical ("med-surg") products and supply chain solutions that serve hospitals, surgery centers, physician offices and post-acute care facilities. The Medline news page on Stock Titan highlights company announcements that explain how it operates as what it describes as the largest provider of med-surg products and supply chain solutions serving all points of care, based on total net sales of med-surg products.
News related to Medline often centers on capital markets activity and corporate milestones, such as the public filing of its registration statement on Form S-1 with the U.S. Securities and Exchange Commission, the pricing of its upsized initial public offering of Class A common stock, and the closing of that upsized offering on the Nasdaq Global Select Market under the symbol MDLN. These updates provide context on Medline’s transition to being a publicly traded company and its use of offering proceeds for debt repayment, general corporate purposes and transactions with pre-IPO owners.
Investors and observers can also find Medline announcements about participation in major healthcare and investor conferences, such as the J.P. Morgan Healthcare Conference. Such events can offer additional insight into how the company presents its med-surg product portfolio, supply chain capabilities and clinical solutions to the investment community.
This news page aggregates these types of press releases and corporate communications so readers can review Medline’s official statements over time. For anyone tracking MDLN, the page offers a focused view of the company’s own disclosures about its business focus, public listing, capital structure and engagement with the broader healthcare and financial markets.
Medline (Nasdaq: MDLN) received two Healthcare Industry Resiliency Collaborative (HIRC) member-choice awards on April 1, 2026: the Highest Member Choice Award for Supplier Partnership and the Distinguished Member Choice Award for Resiliency, and renewed its HIRC Transparency Badge.
These nominations reflect provider recognition for long-term partnership, operational rigor, contingency readiness, and shared, standardized supply-chain visibility.
Medline (Nasdaq: MDLN) broke ground on a new 1.2 million sq. ft. distribution center in Midlothian, Texas, expanding its U.S. network of 45 distribution centers. The facility is expected to be fully operational in Q2 2027 and will include advanced automation such as AutoStore.
The site is Medline's second in the Dallas–Fort Worth area, supports next-day delivery to 95% of U.S. customers, and follows the company’s December 2025 initial public offering.
Medline (Nasdaq: MDLN) closed a secondary offering on March 10, 2026, in which 86,250,000 shares of Class A common stock were sold by selling stockholders at $41.00 per share, and underwriters fully exercised an option to purchase up to 11,250,000 additional shares.
The company did not sell any shares in the offering and did not receive proceeds; the offering was managed by global coordinators including Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan.
Medline (Nasdaq: MDLN) announced its 2025 Distribution Center of the Year and SAFE Award winners, recognizing top-performing U.S. distribution centers across four size tiers. The awards evaluate safety, service, quality, cost and people, and emphasize recordable safety incidents as the primary SAFE metric.
The company operates a 45-center U.S. network and says it provides next-day delivery to 95% of U.S. customers; Richmond, Virginia won both awards.
Medline (Nasdaq: MDLN) priced a secondary offering of 75,000,000 Class A shares at $41.00 per share by selling stockholders affiliated with Blackstone, Carlyle, Hellman & Friedman and ADIA. Underwriters have a 30-day option for an additional 11,250,000 shares.
The offering is expected to close on March 10, 2026. Medline is not selling shares and will not receive proceeds; shares are being sold by the identified selling stockholders.
Medline (Nasdaq: MDLN) announced that certain selling stockholders affiliated with Blackstone, Carlyle, Hellman & Friedman and a subsidiary of Abu Dhabi Investment Authority have commenced an underwritten public offering of 75,000,000 shares of Class A common stock on March 3, 2026.
Underwriters have a 30-day option to purchase up to an additional 11,250,000 shares. Medline will not sell shares and will not receive any proceeds from this offering.
Medline (Nasdaq: MDLN) reported strong full year 2025 results, completed an initial public offering, and issued 2026 guidance.
Key metrics: Q4 net sales $7.8B (+14.8%), Q4 net income $180M (-37.7%), full year net sales $28.4B (+11.5%), full year Adjusted EBITDA $3.5B (+3.2%). Company expects 2026 Organic Sales growth of 8%–9% and Adjusted EBITDA of $3.5–$3.6B.
Medline (Nasdaq: MDLN) said CEO Jim Boyle and CFO Mike Drazin will present at the Barclays 28th Annual Global Healthcare Conference in Miami Beach on March 11, 2026 at 9:30am ET. A live webcast and a replay available for six months will be hosted on Medline's investor relations site.
Medline (Nasdaq: MDLN) will report fourth quarter and full year 2025 results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before market open, followed by a webcast and conference call at 9:30am ET / 8:30am CT.
Investors can access the live webcast and replay on Medline's Events page at ir.medline.com.
Medline (Nasdaq: MDLN) said CEO Jim Boyle and CFO Mike Drazin will present at the J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 3:00 PM PT.
The live presentation will stream on Medline’s investor events page at ir.medline.com, and a replay will be available on the same site for 30 days after the event.